Cost-effectiveness analysis: Adding value to assessment of animal health, welfare and production

OIE Revue Scientifique et Technique

Volumn 33, Issue 3, 2014, Pages 681-689

  Babo Martins, S ^a   Rushton, J ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Animal health; Animal welfare; Cost benefit analysis; Cost effectiveness analysis; Economic assessment

Indexed keywords

ANIMALIA;

ANIMAL; ANIMAL HUSBANDRY; ANIMAL WELFARE; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; STANDARDS;

ANIMAL HUSBANDRY; ANIMAL WELFARE; ANIMALS; COST-BENEFIT ANALYSIS; HUMANS;

EID: 84924356616     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.33.3.2312     Document Type: Article

References (48)

1. Drummond M.E, Sculpher M.J., Torrance G.W, O'Brien B.J. & Stoddart G.L. (2005). - Methods for the evaluation of health care programmes, 3rd Ed. Oxford University Press, New York.
2. Perry B., McDermott J. & Randolph T. (2001). - Can epidemiology and economics make a meaningful contribution to national animal- disease control? Prev. vet. Med., 48 (4), 231-260.
3. Hutubessy R.C.W., Bendib L.M. & Evans D.B. (2001). Critical issues in the economic evaluation of interventions against communicable diseases. Acta trop., 78 (3), 191-206.
4. Cohen D.J. & Reynolds M.R. (2008). Interpreting the results of cost-effectiveness studies. J. Am. Coll. Cardiol., 52 (25), 2119-2126.
5. Petitti D.B. (2000). Meta-analysis, decision-analysis, and cost-effectiveness analysis - methods for quantitative synthesis in medicine, 2nd Ed. Monographs in Epidemiology and Biostatistics 31. Oxford University Press, New York.
6. Schleiniger R. (1999). Comprehensive cost-effectiveness analysis of measures to reduce nitrogen emissions in Switzerland. Ecol. Econ., 30 (1), 147-159.
7. Gold M.R., Siegel J.E., Russell L.B. & Weinstein M.C. (eds) (1996). - Cost-effectiveness in health and medicine. Oxford University Press, New York.
8. Rich K.M., Miller G.Y. & Winter-Nelson A. (2005). - A review of economic tools for the assessment of animal disease outbreaks. Rev. Sci. tech. Off. Int. Epiz., 24 (3), 833-845.
9. Rushton J., Hinrichs J. & Otte M.J. (2009). - Effective use of economic tools for assessing livestock diseases and their control: The case of cost benefit and cost-effectiveness analyses. Poster presented at the 2009 Annual Meeting of the Society for Veterinary Epidemiology and Preventive Medicine, 1-3 April, London. Available at: Www.svepm.org.uk/posters/index.php?path=.%2F2009%2F (accessed in January 2014).
10. Rushton J. (2008). Economic aspects of foot and mouth disease in Bolivia. Rev. sci. tech. Off int. Epiz., 27 (3), 759-769.
11. Gold M.R., Franks P., Siegelberg T. & Sofaer S. (2007). - Does providing cost-effectiveness information change coverage priorities for citizens acting as social decision makers? Hlth Policy, 83 (1), 65-72.
12. Brazier J., Ratcliffe J., Tsuchiya A. & Salomon J. (2007). Measuring and valuing health benefits for economic evaluation. Oxford University Press, New York.
13. Eichler H.G., Kong S.X., Gerth WC, Mavros P & Jonsson B. (2004). - Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Health, 7 (5), 518-528.
14. American College of Physicians (2000). - Primer on cost- effectiveness analysis. Eff. clin. Pract., 3 (5), 253-255.
15. Kishimoto A., Oka T. & Nakanishi J. (2003). - The cost- effectiveness of life-saving interventions in Japan: do chemical regulations cost too much? Chemosphere, 53 (4), 291-299.
16. Vanem E., Endresen Ø. & Skjong R. (2008). Cost- effectiveness criteria for marine oil spill preventive measures. Reliab. Eng. Syst. Safety, 93 (9), 1354-1368.
17. Guarin L., Konovessis D. & Vassalos D. (2009). - Safety level of damaged RoPax ships: risk modelling and cost-effectiveness analysis. Ocean Eng., 36 (12-13), 941-951.
18. Murray C.J., Evans D.B., Acharya A. & Baltussen R.M. (2000). Development of WHO guidelines on generalized cost- effectiveness analysis. Health Econ., 9, 235-251.
19. Rawlins M. (1999). In pursuit of quality: The National Institute for Clinical Excellence. Lancet, 353 (9158), 1079- 1082.
20. Gellynck X., Messens W, Halet D., Grijspeerdt K., Hartnett E. & Viaene J. (2008). - Economics of reducing Campylobacter at different levels within the Belgian poultry meat chain. J. Food Prot., 71 (3), 479-485.
21. Shwiff S.A., Kirkpatrick K.N. & Sterner R.T. (2008). - Economic evaluation of an oral rabies vaccination program for control of a domestic dog-coyote rabies epizootic: 1995-2006. JAVMA, 233 (11), 1736-1741.
22. Hasler B., Regula G., Stark K.D., Sager H., Gottstein B. & Reist M. (2006). - Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland. Prev. vet. Med., 77 (3-4), 230-253.
23. Goldbach S.G. & Alban L. (2006). A cost-benefit analysis of Salmonella-control strategies in Danish pork production. Prev. vet. Med., 77 (1-2), 1-14.
24. Valle PS., Skjerve E., Martin S.W, Larssen R.B., Østeras O. & Nyberg O. (2005). Ten years of bovine virus diarrhoea virus (BVDV) control in Norway: A cost-benefit analysis. Prev. vet. Med., 72 (1-2), 189-207.
25. Boklund A., Toft N., Alban L. & Uttenthal A. (2009). - Comparing the epidemiological and economic effects of control strategies against classical swine fever in Denmark. Prev. vet. Med., 90 (3-4), 180-193.
26. Vellinga Th.V, de Haana M.H.A., Schils R.L.M., Evers A. & van den Pol-van Dasselaar A. (2011). - Implementation of GHG mitigation on intensive dairy farms: farmers' preferences and variation in cost effectiveness. Livest. Sci., 137 (1-3), 185- 195.
27. Van Vlaenderen I., Nautrup B.P. & Gasper S.M. (2011). Estimation of the clinical and economic consequences of non-compliance with antimicrobial treatment of canine skin infections. Prev. vet. Med., 99 (2-4), 201-210.
28. Knight-Jones T.J., Hauser R., Matthes D. & Stark K.D. (2010). Evaluation of effectiveness and efficiency of wild bird surveillance for avian influenza. Vet. Res., 41 (4), 50.
29. Hadorn D.C., Racloz V, Schwermer H. & Stark K.D. (2009). Establishing a cost-effective national surveillance system for bluetongue using scenario tree modelling. Vet. Res., 40 (6), 57.
30. Poulsen Nautrup B. & Van Vlaenderen I. (2009). Cost- effectiveness of pimobendan versus benazepril in acquired myxomatous mitral valve disease in dogs: An adaptation to Switzerland. Value Hlth, 12 (3), PHC4, A62-A62.
31. Poulsen Nautrup B., Poulsen Nautrup C. & Van Vlaenderen I. (2009). - Cost-effectiveness of pimobendan versus benazepril in acquired myxomatous mitral valve disease in dogs in Germany. Value Hlth, 12 (3), PHC3, A62-A62.
32. Simons R., Hill A., de Souza Monteiro D., Fraser R. & Cook A.J.C. (2009). A cost-effectiveness analysis for Salmonella interventions in the British pig meat production chain. In Safe Pork - 8th International Symposium, 30 September to 2 October, Quebec, Canada, 377-380.
33. Benedictus A., Hogeveen H. & Berends B.R. (2009). - The price of the precautionary principle: cost-effectiveness of BSE intervention strategies in the Netherlands. Prev. vet. Med., (3-4), 212-222.
34. Kaare M., Lembo T., Hampson K., Ernest E., Estes A., Mentzel C. & Cleaveland S. (2009). - Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. Vaccine, 27 (1), 152-160.
35. Martínez-López B., Carpenter T.E. & Sanchez-Vizcaino J.M. (2009). - Risk assessment and cost-effectiveness analysis of Aujeszky's disease virus introduction through breeding and fattening pig movements into Spain. Prev. vet. Med., 90 (1-2), 10-16.
36. Pillars R.B., Grooms D.L., Wolf C.A. & Kaneene J.B. (2009). Economic evaluation of Johnefe disease control programs implemented on six Michigan dairy farms. Prev. vet. Med., (3-4), 223-232.
37. Bergevoet R.H., van Schaik G., Veling J., Backus G.B. & Franken P (2009). - Economic and epidemiological evaluation of Salmonella control in Dutch dairy herds. Prev. vet. Med., 89 (1-2), 1-7.
38. Lawson L.G., Jensen J.D., Christiansen P. & Lund M. (2009). Cost-effectiveness of Salmonella reduction in Danish abattoirs. Int. J. Food Microbiol, 134 (1-2), 126-132.
39. Tavornpanich S., Muftoz-Zanzi C.A., Wells S.J., Raizman E.A., Carpenter T.E., Johnson W.O. & Gardner I.A. (2008). - Simulation model for evaluation of testing strategies for detection of paratuberculosis in Midwestern US dairy herds. Prev. vet. Med., 83 (1), 65-82.
40. Valeeva N.I., Huirne R.B.M., Meuwissen M.P.M. & Oude Lansink A.G.J.M. (2007). Modelling farm-level strategies for improving food safety in the dairy chain. Agric. Syst., 94 (2), 528-540.
41. Tavornpanich S., Gardner I.A., Carpenter T.E., Johnson W.O. & Anderson R.J. (2006). - Evaluation of cost-effectiveness of targeted sampling methods for detection of Mycobacterium avium ssp. paratuberculosis infection in dairy herds. Am. J. vet. Res., 67 (5), 821-828.
42. Mangen M.J.J., de Wit G.A. & Havelaar A.H. (2007). - Economic analysis of Campylobacter control in the Dutch broiler meat chain. Agribusiness, 23 (2), 173-192.
43. De Vos C.J., Saatkamp H.W & Huirne R.B.M. (2005). Cost- effectiveness of measures to prevent classical swine fever introduction into the Netherlands. Prev. vet. Med., 70 (3-4), 235-256.
44. Regula G., Lo Fo Wong D.M., Ledergerber U., Stephan R., Danuser J., Bissig-Choisat B. & Stark K.D. (2005). - Evaluation of an antimicrobial resistance monitoring program for Campylobacter in poultry by simulation. Prev. vet. Med., 70 (1-2), 29-43.
45. Roth E, Zinsstag J., Orkhon D., Chimed-Ochir G., Hutton G., Cosivi O., Carrin G. & Otte J. (2003). Human health benefits from livestock vaccination for brucellosis: case study. Bull. WHO, 81 (12), 867-876.
46. Lyons N.A., Smith R.P. & Rushton J. (2012). Cost- effectiveness of farm interventions for reducing the prevalence of VTEC 0157 on UK dairy farms. Epidemiol. Infect., 141 (9), 1905-1919. doi:10.1017/S0950268812002403.
47. Brouwer WB.E & Koopmanschap M.A. (2000). - On the economic foundations of CEA. Ladies and gentlemen, take your positions! J. Hlth Econ., 19 (4), 439-459.
48. Pinkerton S.D., Johnson-Masotti A.P., Derse A. & Layde P.M. (2002). - Ethical issues in cost-effectiveness analysis. Eval. Prog. Plann., 25 (1), 71-83.